Your browser doesn't support javascript.
loading
Loss of IDH mutation or secondary tumour manifestation? Evolution of an IDH-mutant and 1p/19q-codeleted oligodendroglioma after 15 years of continuous temozolomide treatment and radiotherapy: A case report.
Ehret, Felix; Hansch, Alexander; Meinhardt, Jenny; Hain, Elisabeth Gertrud; Misch, Martin; Onken, Julia; Roohani, Siyer; Koch, Arend; Schweizer, Leonille; Radke, Josefine; Kaul, David.
Affiliation
  • Ehret F; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Hansch A; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Berlin, Germany.
  • Meinhardt J; Charité - Universitätsmedizin Berlin, Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hain EG; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Berlin, Germany.
  • Misch M; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Berlin, Germany.
  • Onken J; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Berlin, Germany.
  • Roohani S; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurosurgery, Berlin, Germany.
  • Koch A; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurosurgery, Berlin, Germany.
  • Schweizer L; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Berlin, Germany.
  • Radke J; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Berlin, Germany.
  • Kaul D; Charité - Universitätsmedizin Berlin, Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Neuropathol Appl Neurobiol ; 49(1): e12859, 2023 02.
Article in En | MEDLINE | ID: mdl-36332636
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligodendroglioma / Brain Neoplasms / Glioma Limits: Humans Language: En Journal: Neuropathol Appl Neurobiol Year: 2023 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligodendroglioma / Brain Neoplasms / Glioma Limits: Humans Language: En Journal: Neuropathol Appl Neurobiol Year: 2023 Type: Article Affiliation country: Germany